Natriumbicarbonate Braun (Sodium Hydrogen Carbonate)

Sodium bicarbonate dissociates into sodium and bicarbonate ions after infusion. The bicarbonate ions combine with excess hydrogen ions in the blood to form carbonic acid, which quickly converts to water and carbon dioxide. This reaction reduces hydrogen ion concentration, raising blood pH and correcting the acidotic state.

The prescribed dose of Natriumbicarbonate Braun is individualized by the treating physician based on the patient’s current acid‑base status, serum electrolyte levels, body weight, and underlying clinical condition. Dosing calculations typically use arterial blood gas results and target pH values to guide the amount of bicarbonate required.

Safety data for Natriumbicarbonate Braun in pregnancy and lactation are limited, and the product’s pregnancy category is not established. Use is generally reserved for situations where the potential benefit outweighs any possible risk to the fetus or infant, and only under close medical supervision.

To order Natriumbicarbonate Braun, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including cold‑chain if needed), and required import documentation.

Natriumbicarbonate Braun provides direct bicarbonate ions, offering rapid correction of acidosis compared with agents such as tromethamine or carbicarb, which require metabolic conversion. Its intravenous formulation allows precise dosing and immediate effect, whereas oral agents have slower onset and variable absorption.

Store Natriumbicarbonate Braun at 2‑8 °C in a refrigerator. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. Do not use if the product appears discolored or contains particles.

Natriumbicarbonate Braun is administered intravenously, usually via a controlled infusion pump or slow manual injection. The infusion rate and total volume are determined by the prescriber based on the patient’s acid‑base measurements and clinical response, with continuous monitoring of vital signs and laboratory parameters.

Serious risks include severe metabolic alkalosis, which can depress respiration, pulmonary edema from fluid overload, cardiac arrhythmias due to electrolyte disturbances, and rare anaphylactoid reactions. Prompt recognition of symptoms such as dyspnea, chest pain, or sudden changes in mental status is essential.

Patients with known hypersensitivity to sodium bicarbonate, uncontrolled severe hypertension, uncompensated heart failure, or those at high risk for rapid fluid overload should generally avoid Natriumbicarbonate Braun. Additionally, individuals with severe renal impairment may require dose adjustment or alternative therapy.